Board Meetings for BALPHARMA
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| BALPHARMA | Bal Pharma Limited | 12 Feb 2020 | Financial Results | To consider and approve the financial results for the period ended December 31, 2019 | |
| BALPHARMA | Bal Pharma Limited | 14 Nov 2019 | Financial Results | To consider and approve the financial results for the period ended September 30, 2019 | |
| BALPHARMA | Bal Pharma Limited | 08 Aug 2019 | Financial Results/Other business matters | BALPHARMA : 13-Aug-2019 : The Company has informed the Exchange that a Board meeting to be held on August 08, 2019 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on August 13, 2019, To consider and approve the financial results for the period ended Jun 30, 2019 and other business matters | |
| BALPHARMA | Bal Pharma Limited | 08 Aug 2019 | Financial Results | To inter alia consider and approve the financial results for the period ended Jun 30, 2019. | |
| BALPHARMA | Bal Pharma Limited | 29 May 2019 | Financial Results | To consider and approve the financial results for the period ended March 31, 2019 and Closure of Trading Window. | |
| BALPHARMA | Bal Pharma Limited | 29 May 2019 | Financial Results/Dividend | BALPHARMA : 30-May-2019 : The Company has informed the Exchange that a Board meeting to be held on May 29, 2019 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 30, 2019, To consider and approve the financial results for the period ended March 31, 2019 and dividend | |
| BALPHARMA | Bal Pharma Limited | 13 Feb 2019 | Financial Results | To consider and approve the financial results for the period ended December 31, 2018 | |
| BALPHARMA | Bal Pharma Limited | 14 Nov 2018 | Financial Results | Inter alia will be considering approval of Un-audited stand alone and consolidated financial results of the Company for the quarter and half year ended September 30, 2018. | |
| BALPHARMA | Bal Pharma Limited | 10 Aug 2018 | Financial Results/Other business matters | To Inter alia consider the following, a) Approval of the Un-audited financial results of the Company for the Quarter ended June 30, 2018. b) To decide on the Book closure and t Annual General Meeting dates. c) Other Annual General Meeting related matters. | |
| BALPHARMA | Bal Pharma Limited | 29 May 2018 | Financial Results/Dividend | inter alia will be considering. 1) Approval of Audited Stand Alone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2018. 2) Appropriation of profits including recommendation of dividend if any for the financial year 2017-18 | |
| BALPHARMA | Bal Pharma Limited | 14 Feb 2018 | Results | The Board of Directors inter alia will be considering approval of un audited stand alone and consolidated financial results of the Company for the quarter ended December 31, 2017. | |
| BALPHARMA | Bal Pharma Limited | 11 Dec 2017 | Results | Inter alia will be considering approval of un audited stand alone and consolidated financial results of the Company for the quarter and half year ended September 30, 2017. | |
| BALPHARMA | Bal Pharma Limited | 11 Sept 2017 | Results | Inter alia will be considering approval of Ind-AS compliant, un-audited stand alone and consolidated financial results of the Company for the quarter ended June 30, 2017. | |
| BALPHARMA | Bal Pharma Limited | 10 Aug 2017 | Others | inter alia will be transacting the following business. 1.To approve the 30th Annual General Meeting Notice (AGM), Directors Report and Corporate Governance reports of the Company, for the financial year ended March 31, 2017. 2. To decided on the Book closure dates. 3. To consider other AGM related matters　 | |
| BALPHARMA | Bal Pharma Limited | 30 May 2017 | Results | Inter alia, Considering approval of audited stand alone and consolidated financial results of the Company for the financial year 2016.17. Further, pursuant to Prohibition of Insider Trading Regulations,2015 of SEBI and as per the provisions of Code of Conduct of the Company, the trading window on the designated employees of the Company and their immediate relatives will remain closed from 12.05.2017 up to 31.05.2017. |